eli lilly glp-1 dominance Lilly's portfolio gains ground on Novo Nordisk Eli Lilly's New GLP‑1 Pill

And myself and many of the other people you've heard on this podcast, we don't see people have to stay on GLP ones for life

Impact of pharmacist intervention to improve medication access for patients with diabetes

It signals the pancreas to produce insulin secretion when blood sugar levels rise

By constantly signaling to the brain that the body is full, peristalsis (rippling GI waves that push contents through the gut) is slowed, thereby disrupting the bodys natural digestion process. According to Fereday: The anecdotes of the early adopters are not necessarily that representative of how things will play out if this class of drugs goes mainstream

Liu C, Li C, Cai X, et al